Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122121) titled 'Al18F-NOTA-LM3 PET/CT imaging in somatostatin receptor-positive tumors' on April 9.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Peking Union Medical College Hospital
Condition:
Gastroenteropancreatic neuroendocrine tumors (GEP-NETs), pheochromocytomas, paragangliomas, tumor-induced osteomalacia (TIO), and other somatostatin receptor-positive tumors
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2023-03-23
Target Sample Size: Patients with suspected or confirmed neuroendocrine tumors:50;
Countries of Recruitment:
China
To know more, visit https://...